Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
Hao Yu, Xiaojie Liu, Bixuan Chen, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3548-3548
Open Access | Times Cited: 25

Showing 25 citing articles:

CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 27
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson’s disease and neuronal damage through inhibition of microglia
Xi-Qing Chai, Shengjun An, Zhongxia Zhang, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2291-2291
Open Access | Times Cited: 24
Parkinson’s Disease: Exploring Different Animal Model Systems
Engila Khan, Ikramul Hasan, M. Emdadul Haque
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9088-9088
Open Access | Times Cited: 20
Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
Yangzhi Xie, Liang Chen, Jiacheng Chen, et al.
Brain and Behavior (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 6
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access
Microglial cannabinoid receptor 2 and epigenetic regulation: implications for the treatment of depression
Priyanka Sharma, Rajni Daksh, Saumya Khanna, et al.
European Journal of Pharmacology (2025), pp. 177422-177422
Open Access
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases
Ramona Meanti, Elena Bresciani, Laura Rizzi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118044-118044
Closed Access
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 4
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
María Fernanda Urmeneta-Ortíz, Aldo Rafael Tejeda-Martínez, Orfil González‐Reynoso, et al.
Parkinson s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 4
Adolescent mice exposed to TBI developed PD-like pathology in middle age
Rong Sha, Mingzhe Wu, Pengfei Wang, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition
Vittoria Borgonetti, Claudia Mugnaini, Federico Corelli, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1546-1546
Open Access | Times Cited: 9
cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement
Lianwei Mu, Xiaojie Liu, Hao Yu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3930-3942
Open Access | Times Cited: 9
Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence
Luis Ángel Monsalvo-Maraver, Enid A. Ovalle-Noguez, Jade Nava-Osorio, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 3
JWH133 attenuates behavior deficits and iron accumulation in the 6-OHDA-induced Parkinson's disease model rats
Man Liu, Dong Pan, MengYa Wang, et al.
Journal of Neurophysiology (2024) Vol. 132, Iss. 3, pp. 733-743
Closed Access | Times Cited: 3
Endocannabinoid signaling in the central nervous system
César E. Martinez Ramirez, Gonzalo Ruiz‐Pérez, Todd M. Stollenwerk, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 5-35
Open Access | Times Cited: 15
Experimental Parkinson models and green chemistry approach
Özge AKYAZI, Dılara Korkmaz, Şule Çoşkun Cevher
Behavioural Brain Research (2024) Vol. 471, pp. 115092-115092
Closed Access | Times Cited: 2
Mouse Model of Parkinson’s Disease with Bilateral Dorsal Striatum Lesion with 6-Hydroxydopamine Exhibits Cognitive Apathy-like Behavior
Masato Okitsu, Masayo Fujita, Yuki Moriya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7993-7993
Open Access | Times Cited: 2
Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats
Jie Yin, Yang Li, Dan Li, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 12, pp. 1996-2005
Open Access | Times Cited: 2
CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice
Xiaojie Liu, Hao Yu, Bixuan Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1776-1776
Open Access | Times Cited: 10
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
Ivona Maria Tudorancea, Mitică Ciorpac, Gabriela Dumitrița Stanciu, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2492-2492
Open Access | Times Cited: 8
Specific Activation of CB2R Ameliorates Psoriasis-Like Skin Lesions by Inhibiting Inflammation and Oxidative Stress
Yufeng He, Honglin Jia, Qunfang Yang, et al.
Inflammation (2023) Vol. 46, Iss. 4, pp. 1255-1271
Closed Access | Times Cited: 4
Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8520-8520
Open Access | Times Cited: 1
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Maria Sofia Basile, Emanuela Mazzon
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2986-2986
Open Access | Times Cited: 7
Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis
Berzenn Urbi, Yunjoo Lee, Ian Hughes, et al.
BMJ Open Science (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Dephosphorylation of Six2Y129 protects tyrosine hydroxylase-positive cells in SNpc by regulating TEA domain 1 expression
Can-tang Zhang, Deng-li Qin, Xia-yin Cao, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107049-107049
Open Access | Times Cited: 2
Page 1

Scroll to top